SE322868B - - Google Patents

Info

Publication number
SE322868B
SE322868B SE11223/64A SE1122364A SE322868B SE 322868 B SE322868 B SE 322868B SE 11223/64 A SE11223/64 A SE 11223/64A SE 1122364 A SE1122364 A SE 1122364A SE 322868 B SE322868 B SE 322868B
Authority
SE
Sweden
Application number
SE11223/64A
Inventor
B Alhede
Original Assignee
Medica Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Ab Oy filed Critical Medica Ab Oy
Publication of SE322868B publication Critical patent/SE322868B/xx

Links

SE11223/64A 1963-09-20 1964-09-18 SE322868B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK442563AA DK103141C (da) 1963-09-20 1963-09-20 Fremgangsmåde til fremstilling af stabile, injicerbare opløsninger af hydroxocobalamin.

Publications (1)

Publication Number Publication Date
SE322868B true SE322868B (da) 1970-04-20

Family

ID=8133400

Family Applications (1)

Application Number Title Priority Date Filing Date
SE11223/64A SE322868B (da) 1963-09-20 1964-09-18

Country Status (3)

Country Link
DK (1) DK103141C (da)
FI (1) FI41589B (da)
SE (1) SE322868B (da)

Also Published As

Publication number Publication date
FI41589B (da) 1969-09-01
DK103141C (da) 1965-11-22

Similar Documents

Publication Publication Date Title
AR142945A1 (da)
AT260747B (da)
FI41589B (da)
BE627012A (da)
BE31062A (da)
BE462764A (da)
BE465565A (da)
BE507458A (da)
BE533484A (da)
BE547422A (da)
BE571209A (da)
BE582314A (da)
BE603935A (da)
BE608372A (da)
BE612803A (da)
BE614220A (da)
BE616247A (da)
BE616830A (da)
BE616967A (da)
BE619061A (da)
BE620325A (da)
BE621232A (da)
BE621517A (da)
BE622160A (da)
BE623117A (da)